Liskova Petra

Member info

Pr Petra Liskova

Representative

Czech Republic

Working Group Leader: Anterior Segment Rare Eye Diseases (WG4)

Other Working Group(s): Retinal Rare Eye Diseases (WG1), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), Research (TWG8), National Integration (TWG9)

Team

PhD Bohdan Kousal

Czech Republic

Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8), Retinal Rare Eye Diseases (WG1)

Dr Pavel Diblik

Czech Republic

Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Retinal Rare Eye Diseases (WG1)

Dr Marek Fichtl

Czech Republic

Anterior Segment Rare Eye Diseases (WG4), Neuro-Ophthalmology Rare Diseases (WG2)

Pr Jarmila Heissigerova

Czech Republic

Retinal Rare Eye Diseases (WG1)

Dr Marcela Michalickova

Czech Republic

Genetic Diagnostics (TWG6), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8)

Dr Pavlina Skalicka

Czech Republic

Anterior Segment Rare Eye Diseases (WG4), Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8)

Dr Marie Vajter

Czech Republic

Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)

Dr Andrea Vergaro

Czech Republic

Research (TWG8), Retinal Rare Eye Diseases (WG1)

Dr Lukas Huna

Czech Republic

Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5)

Dr Helena Kabesova

Czech Republic

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)

HCP Center

The General University Hospital in Prague is one of the biggest healthcare facilities in the Czech Republic. It provides basic, specialized and very...

More >

contact

Center of Clinical Ophthalmic Genetics, Department of Ophthalmology, General University Hospital in Prague, Czech Republic

U Nemocnice 499/2

128 08 Prague

Czech Republic

420 224 961 111

Visit Website

Clinical trials

Go to the clinical trials main page

NCT04423718 Completed

Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Interventional

See the trial

NCT05384249 Active, Not recruiting

A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Non-infectious, Intermediate-, Posterior- or Pan-uveitis

Interventional

See the trial

Scientific publications

Keratoconus in Children: A Literature Review

This review discusses the main aspects of pediatric keratoconus (KC) based on the current evidence to propose a guideline for helping early...

Phenotype Variability in Czech Patients Carrying PAX6 Disease-Causing Variants

The aim of this study was to report PAX6 disease-causing variants in six Czech families, to describe the associated phenotypes, and to perform...

Multirater Validation of Peripapillary Hyperreflective Ovoid Mass-like Structures (PHOMS)

We performed a Delphi consensus process to develop a consistent and refined definition of PHOMS with clear principles around the nature of PHOMS...

The need for widely available genomic testing in rare eye diseases: an ERN‑EYE position statement

ERN-EYE promotes access to genetic testing in RED and emphasizes the clinical need and relevance of genetic testing in...

Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia

We provide extensive in silico analyses and summarize reported functional data of previously analyzed missense, nonsense and splicing variants to...

Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy

Van de Sompele et al. used multiomics profiling and in vitro and in vivo enhancer assays to dissect the regulatory mechanisms underlying North...

Disease-Causing TIMP3 Variants and Deep Phenotyping of Two Czech Families with Sorsby Fundus Dystrophy Associated with Novel p.(Tyr152Cys) Mutation

We aim to report the ocular phenotype and molecular genetic findings in two Czech families with Sorsby fundus dystrophy and to review all the...

Diagnosis and classification of optic neuritis

There is no consensus regarding the classification of optic neuritis, and precise diagnostic criteria are not...

CUGC for posterior polymorphous corneal dystrophy (PPCD)

Review of the analytical and clinical validity as well as of the clinical utility of DNA-based testing for variants in theOVOL2,...

The utility of massively parallel sequencing for posterior polymorphous corneal dystrophy type 3 molecular diagnosis

The aim of this study was to identify the molecular genetic cause of disease in posterior polymorphous corneal dystrophy (PPCD) probands of...

Analysis of KERA in four families with cornea plana identifies two novel mutations

To identify the molecular genetic cause in four families of various ethnic backgrounds with cornea...

Paraproteinemic keratopathy associated with monoclonal gammopathy of undetermined significance (MGUS): clinical findings in twelve patients including recurrence after keratoplasty

To describe the ocular findings of 12 subjects with paraproteinemic keratopathy associated with monoclonal gammopathy of undetermined significance...

Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes

Genetic and Demographic Determinants of Fuchs Endothelial Corneal Dystrophy Risk and Severity

See more scientific publications

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Accessibility

Pr Petra Liskova

In this page

Member info

Pr Petra Liskova

Team

PhD Bohdan Kousal

Dr Pavel Diblik

Dr Marek Fichtl

Pr Jarmila Heissigerova

Dr Marcela Michalickova

Dr Pavlina Skalicka

Dr Marie Vajter

Dr Andrea Vergaro

Dr Lukas Huna

Dr Helena Kabesova

HCP Center

contact

Center of Clinical Ophthalmic Genetics, Department of Ophthalmology, General University Hospital in Prague, Czech Republic

Clinical trials

Scientific publications

Keratoconus in Children: A Literature Review

Phenotype Variability in Czech Patients Carrying PAX6 Disease-Causing Variants

Multirater Validation of Peripapillary Hyperreflective Ovoid Mass-like Structures (PHOMS)

The need for widely available genomic testing in rare eye diseases: an ERN‑EYE position statement

Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia

Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy

Disease-Causing TIMP3 Variants and Deep Phenotyping of Two Czech Families with Sorsby Fundus Dystrophy Associated with Novel p.(Tyr152Cys) Mutation

Diagnosis and classification of optic neuritis

CUGC for posterior polymorphous corneal dystrophy (PPCD)

The utility of massively parallel sequencing for posterior polymorphous corneal dystrophy type 3 molecular diagnosis

Analysis of KERA in four families with cornea plana identifies two novel mutations

Paraproteinemic keratopathy associated with monoclonal gammopathy of undetermined significance (MGUS): clinical findings in twelve patients including recurrence after keratoplasty

Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes

Genetic and Demographic Determinants of Fuchs Endothelial Corneal Dystrophy Risk and Severity

CONTACT US